However, CD276 and its exact downstream cascade are still under investigation, and divergent results have been obtained for CD276 on whether it acts as a co-stimulator or co-inhibitor of T cell-mediated immune responses in different tumor types [13,14]. Here, CD276 is linked to neoplasm.